LETTER FROM LEADERSHIP
Letter from Leadership 2025
At Casey Eye Institute, innovation meets compassion in the pursuit of advancing eye health and vision care. From groundbreaking research to transformative technologies like telehealth and AI, we are committed to ending preventable blindness. Discover how our leadership and collaboration are shaping the future of eye care.
LETTER FROM LEADERSHIP
Letter from Leadership 2024
We had an exceptional year in 2023. Growth in the community outreach program, extraordinary faculty recognition, and the excellence of our Casey community continues to fuel our desire to invest in innovation. We’ve never been more committed to reaching our goal to end preventable blindness in Oregon and beyond. We are grateful for the opportunity to share exciting work from a few of our programs in this year's Innovations.
Advancing Imaging
Advancing Uveitis Care Through AI and Ultra-High Resolution OCT
At OHSU's Casey Eye Institute, researchers are combining artificial intelligence with ultra-high-resolution optical coherence tomography imaging to tackle uveitis. Using this breakthrough approach, they are not only able to count white blood cells, but also identify their location and type.
Inside the Lab
Lipid Nanoparticles Revolutionize Gene Therapy for Eye Diseases
Unlocking the future of vision care, Dr. Renee Ryals and her team are revolutionizing gene therapy with cutting-edge lipid nanoparticle technology. The new LNP delivery systems may expand therapeutics options for genetic eye disease treatment and offer hope to patients.
Data-Driven Medicine
Transforming Glaucoma Detection
Research team is pioneering the future of glaucoma detection with an AI-powered tool that assesses glaucoma risk using electronic health record data. This innovative approach enables early identification without the need for specialized eye exams, expanding access to essential eye care.
